Webinar - Ask the expert: FLT3 MRD testing in AML patients
2026-03-17 17:00 - 18:00 (Europe/Paris)
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda:
Assess the current minimal residual disease testing modalities/methods
 Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities
 Summarize the appropriate treatment strategies in a post-transplant setting
 Best practice sharing in developing/setting up FLT3 MRD testing
More info and register here.

Germline Predisposition to Myeloid Neoplasms – Case discussions
2026-05-07 15:00 - 16:00
Join the MDR for patients with germline predisposition for hematological malignancies.
This meeting is for clinicians within the Nordics.via this Zoom-link.
If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

NAMLG meeting @ EHA2026
2026-06-13 00:30 - 14:00

AML Course Day 2026 - Bergen
2026-09-16 08:00 - 17:00

Nordic AML Meeting 2026 - Bergen
2026-09-17 - 2026-09-18
